Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anthony Chau

Vascular Surgery Orange, CA Medical Doctor

NPI 1699055988 CMS profile 1389716

101 The City Dr S, Orange, CA 92868

Open in the dashboard

General payments

$57,018

322 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$168,968 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Anthony Chau of Orange, CA is reported in the CMS Open Payments database as having received $57,018 across 322 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $168,968 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,814 88
2024 General $21,827 77
2023 General $8,520 52
2022 General $8,745 44
2021 General $961 27
2020 General $384 14
2019 General $768 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Chau
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Anthony Chau were reported at $15,814. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Anthony Chau Vascular Surgery median Middle half National median
2019 $768 $796 $226–$2,363 $163
2020 $384 $348 $118–$1,110 $114
2021 $961 $471 $158–$1,421 $132
2022 $8,745 $725 $222–$2,183 $149
2023 $8,520 $836 $257–$2,440 $160
2024 $21,827 $909 $252–$2,619 $164
2025 $15,814 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $31,449 32 payments
  2. Stryker Corporation $9,646 8 payments
  3. Medtronic, Inc. $5,414 66 payments
  4. W. L. Gore & Associates, Inc. $3,867 70 payments
  5. Cook Medical LLC $1,942 49 payments
  6. Silk Road Medical, Inc. $1,536 35 payments
  7. Bolton Medical Inc $523 9 payments
  8. Shockwave Medical, Inc $450 5 payments
  9. Philips Electronics North America Corporation $219 4 payments
  10. Ethicon US, LLC $193 2 payments
  11. Other $1,781 42 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $28,950 12 payments
  2. Food and Beverage $13,670 289 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,675 9 payments
  4. Travel and Lodging $1,723 12 payments
Products named General payments · program years 2019–2025
  1. CT THROMBECTOMY SYSTEM KIT $40,920 36 payments
  2. FLOWTRIEVER CATHETER, S $40,920 36 payments
  3. ENDURANT IIS $2,627 46 payments
  4. ENROUTE Transcarotid Stent $1,288 26 payments
  5. ENROUTE Transcarotid Neuroprotection System $1,288 26 payments
  6. GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis $1,074 15 payments
  7. GORE TAG Thoracic Endoprosthesis $926 6 payments
  8. Valiant Captivia $835 14 payments
  9. Zilver PTX $608 11 payments
  10. GORE EXCLUDER Iliac Branch Endoprosthesis $458 13 payments
  11. Other $9,344 230 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Vascular Surgery: 122

Drug cost

$204

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 14 $204

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$29,728

Medicare's payments for the services billed

Medicare patients

112

Average age 74

Services billed

251

44 women, 68 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 64%
Chronic kidney disease 63%
Diabetes 61%
Arthritis 57%
Heart failure 46%
Depression 40%
Atrial fibrillation 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

322 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record